Advanced search
Publication Cover
Expert Review of Vaccines Volume 1, 2002 - Issue 1
Submit an article Journal homepage
963
Views
233
CrossRef citations to date
0
Altmetric
Review

Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines

Jerome Aucouturier SEPPIC, 75 Quai D’Orsay, 75321 Paris, Cedex 07, France. [email protected]
,
L Dupuis SEPPIC, 75 Quai D’Orsay, 75321 Paris, Cedex 07, France. [email protected]
,
S Deville SEPPIC, 75 Quai D’Orsay, 75321 Paris, Cedex 07, France. [email protected]
,
S Ascarateil SEPPIC, 75 Quai D’Orsay, 75321 Paris, Cedex 07, France. [email protected]
&
V Ganne SEPPIC, 75 Quai D’Orsay, 75321 Paris, Cedex 07, France. [email protected]
Pages 111-118 | Published online: 09 Jan 2014

Citations (233)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (24)

Yarong Zeng, Feihong Zou, Ningshao Xia & Shaowei Li. (2023) In-depth review of delivery carriers associated with vaccine adjuvants: current status and future perspectives. Expert Review of Vaccines 22:1, pages 681-695.
Read now
Md Mohosin Rana. (2021) Polymer-based nano-therapies to combat COVID-19 related respiratory injury: progress, prospects, and challenges. Journal of Biomaterials Science, Polymer Edition 32:9, pages 1219-1249.
Read now
Sunita, Andaleeb Sajid, Yogendra Singh & Pratyoosh Shukla. (2020) Computational tools for modern vaccine development. Human Vaccines & Immunotherapeutics 16:3, pages 723-735.
Read now
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer & Erika Vacchelli. (2020) Trial watch: TLR3 agonists in cancer therapy. OncoImmunology 9:1.
Read now
Nur Haziqah Che Marzuki, Roswanira Abdul Wahab & Mariani Abdul Hamid. (2019) An overview of nanoemulsion: concepts of development and cosmeceutical applications. Biotechnology & Biotechnological Equipment 33:1, pages 779-797.
Read now
Monika Kaurav, Jitender Madan, M. S. Sudheesh & Ravi Shankar Pandey. (2018) Combined adjuvant-delivery system for new generation vaccine antigens: alliance has its own advantage. Artificial Cells, Nanomedicine, and Biotechnology 46:sup3, pages 818-831.
Read now
Eva van Doorn, Heng Liu, Anke Huckriede & Eelko Hak. (2016) Safety and tolerability evaluation of the use of Montanide ISA™51 as vaccine adjuvant: A systematic review. Human Vaccines & Immunotherapeutics 12:1, pages 159-169.
Read now
Jonathan Pol, Norma Bloy, Aitziber Buqué, Alexander Eggermont, Isabelle Cremer, Catherine Sautès-Fridman, Jérôme Galon, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial Watch: Peptide-based anticancer vaccines. OncoImmunology 4:4.
Read now
Abid H. Banday, Salika Jeelani & Victor J. Hruby. (2015) Cancer vaccine adjuvants – recent clinical progress and future perspectives. Immunopharmacology and Immunotoxicology 37:1, pages 1-11.
Read now
Antu K Dey, Padma Malyala & Manmohan Singh. (2014) Physicochemical and functional characterization of vaccine antigens and adjuvants. Expert Review of Vaccines 13:5, pages 671-685.
Read now
Robert O Dillman. (2013) Melanoma vaccines: trials and tribulations. Vaccine: Development and Therapy 3, pages 57-78.
Read now
Daniela Fenoglio, Paolo Traverso, Alessia Parodi, Francesca Kalli, Maurizio Zanetti & Gilberto Filaci. (2013) Generation of more effective cancer vaccines. Human Vaccines & Immunotherapeutics 9:12, pages 2543-2547.
Read now
Christopher B Fox & Jean Haensler. (2013) An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants. Expert Review of Vaccines 12:7, pages 747-758.
Read now
Derek T O’Hagan, Gary S Ott, Gary Van Nest, Rino Rappuoli & Giuseppe Del Giudice. (2013) The history of MF59® adjuvant: a phoenix that arose from the ashes. Expert Review of Vaccines 12:1, pages 13-30.
Read now
Darren R Flower. (2012) Systematic identification of small molecule adjuvants. Expert Opinion on Drug Discovery 7:9, pages 807-817.
Read now
Josianne Nitcheu Tefit & Vincent Serra. (2011) Outlining novel cellular adjuvant products for therapeutic vaccines against cancer. Expert Review of Vaccines 10:8, pages 1207-1220.
Read now
Franco M Buonaguro, Maria Lina Tornesello & Luigi Buonaguro. (2011) New adjuvants in evolving vaccine strategies. Expert Opinion on Biological Therapy 11:7, pages 827-832.
Read now
Elena Mata, Manoli Igartua, Rosa M. Hernández, Jaiver E. Rosas, Manuel E. Patarroyo & José L. Pedraz. (2010) Comparison of the adjuvanticity of two different delivery systems on the induction of humoral and cellular responses to synthetic peptides. Drug Delivery 17:7, pages 490-499.
Read now
Matthew Black, Amanda Trent, Matthew Tirrell & Colleen Olive. (2010) Advances in the design and delivery of peptide subunit vaccines with a focus on Toll-like receptor agonists. Expert Review of Vaccines 9:2, pages 157-173.
Read now
Chandana Mohanty, Geetanjali Arya, RamaS. Verma & SanjeebK. Sahoo. (2009) Nanobiotechnology: Application of Nanotechnology in Therapeutics and Diagnosis. International Journal of Green Nanotechnology: Biomedicine 1:1, pages B24-B38.
Read now
Pernille Nordly, Henriette Baun Madsen, Hanne Moerck Nielsen & Camilla Foged. (2009) Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators. Expert Opinion on Drug Delivery 6:7, pages 657-672.
Read now
Frederick R Vogel, Catherine Caillet, Inca C Kusters & Jean Haensler. (2009) Emulsion-based adjuvants for influenza vaccines. Expert Review of Vaccines 8:4, pages 483-492.
Read now
Derek T O’Hagan. (2007) MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection. Expert Review of Vaccines 6:5, pages 699-710.
Read now
Cara K Fraser, Kerrilyn R Diener, Michael P Brown & John D Hayball. (2007) Improving vaccines by incorporating immunological coadjuvants. Expert Review of Vaccines 6:4, pages 559-578.
Read now

Articles from other publishers (209)

Sivakumar S. Moni, Siddig Ibrahim Abdelwahab, Aamena Jabeen, Mohamed Eltaib Elmobark, Duaa Aqaili, Gassem Ghoal, Bassem Oraibi, Abdulla Mohammed Farasani, Ahmed Ali Jerah, Mahdi Mohammed A. Alnajai & Abdul Majeed Hamad Mohammad Alowayni. (2023) Advancements in Vaccine Adjuvants: The Journey from Alum to Nano Formulations. Vaccines 11:11, pages 1704.
Crossref
Rajneesh, Rahul Tiwari, Vishal K. Singh, Awnish Kumar, Rohit P. Gupta, Akhilesh K. Singh, Vibhav Gautam & Rajiv Kumar. (2023) Advancements and Challenges in Developing Malaria Vaccines: Targeting Multiple Stages of the Parasite Life Cycle. ACS Infectious Diseases.
Crossref
Laura Jane Bishop, Christian Stutzer & Christine Maritz-Olivier. (2023) More than Three Decades of Bm86: What We Know and Where to Go. Pathogens 12:9, pages 1071.
Crossref
Jonas S. Heitmann, Claudia Tandler, Maddalena Marconato, Annika Nelde, Timorshah Habibzada, Susanne M. Rittig, Christian M. Tegeler, Yacine Maringer, Simon U. Jaeger, Monika Denk, Marion Richter, Melek T. Oezbek, Karl-Heinz Wiesmüller, Jens Bauer, Jonas Rieth, Marcel Wacker, Sarah M. Schroeder, Naomi Hoenisch Gravel, Jonas Scheid, Melanie Märklin, Annika Henrich, Boris Klimovich, Kim L. Clar, Martina Lutz, Samuel Holzmayer, Sebastian Hörber, Andreas Peter, Christoph Meisner, Imma Fischer, Markus W. Löffler, Caroline Anna Peuker, Stefan Habringer, Thorsten O. Goetze, Elke Jäger, Hans-Georg Rammensee, Helmut R. Salih & Juliane S. Walz. (2023) Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency. Nature Communications 14:1.
Crossref
Tingmei Zhao, Yulong Cai, Yujie Jiang, Xuemei He, Yuquan Wei, Yifan Yu & Xiaohe Tian. (2023) Vaccine adjuvants: mechanisms and platforms. Signal Transduction and Targeted Therapy 8:1.
Crossref
Sedthawut Laotee, Methawee Duangkaew, Araya Jivapetthai, Kittipan Tharakhet, Papatsara Kaewpang, Eakachai Prompetchara, Supaporn Phumiamorn, Sompong Sapsutthipas, Sakalin Trisiriwanich, Thitiporn Somsaard, Sittiruk Roytrakul, Parichat Duangkhae, Boonsri Ongpipattanakul, Patanachai Limpikirati, Natapol Pornputtapong & Wanatchaporn Arunmanee. (2023) CHO-produced RBD-Fc subunit vaccines with alternative adjuvants generate immune responses against SARS-CoV-2. PLOS ONE 18:7, pages e0288486.
Crossref
Brankica Filipić, Ivana Pantelić, Ines Nikolić, Dragomira Majhen, Zorica Stojić-Vukanić, Snežana Savić & Danina Krajišnik. (2023) Nanoparticle-Based Adjuvants and Delivery Systems for Modern Vaccines. Vaccines 11:7, pages 1172.
Crossref
Niloofar Khairkhah, Fatemeh Shahhosseini, Elnaz Agi, Alireza Milani & Azam Bolhassani. (2023) Comparison of Adjuvant Effects of Montanide ISA-720 and Heat Shock Protein 27 in Increasing Immunostimulatory Properties of HIV-1 Nef-Vif Fusion Protein Construct. Protein & Peptide Letters 30:5, pages 401-410.
Crossref
Chia-Jung Li, Chung-Lin Jiang, Tai-Ling Chao, Shiau-Yu Lin, Ya-Min Tsai, Chong-Syun Chao, Yu-Ting Su, Chun-Jen Chen, Sui-Yuan Chang, Fu-Jung Lin & Shih-Chung Chang. (2023) Elicitation of potent neutralizing antibodies in obese mice by ISA 51-adjuvanted SARS-CoV-2 spike RBD-Fc vaccine. Applied Microbiology and Biotechnology 107:9, pages 2983-2995.
Crossref
Bryan J. Neth, Mason J. Webb, Ian F. Parney & Ugur T. Sener. (2023) The Current Status, Challenges, and Future Potential of Therapeutic Vaccination in Glioblastoma. Pharmaceutics 15:4, pages 1134.
Crossref
Eline A. Feitsma, Yester F. Janssen, Hendrikus H. Boersma, Yannick van Sleen, Debbie van Baarle, David G. Alleva, Thomas M. Lancaster, Thillainaygam Sathiyaseelan, Sylaja Murikipudi, Andrea R. Delpero, Melanie M. Scully, Ramya Ragupathy, Sravya Kotha, Jeffrey R. Haworth, Nishit J. Shah, Vidhya Rao, Shashikant Nagre, Shannon E. Ronca, Freedom M. Green, Ari Aminetzah, Frans Sollie, Schelto Kruijff, Maarten Brom, Gooitzen M. van Dam & Todd C. Zion. (2023) A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452. Vaccine 41:13, pages 2184-2197.
Crossref
Sarah M. Schroeder, Annika Nelde & Juliane S. Walz. (2023) Viral T-cell epitopes – Identification, characterization and clinical application. Seminars in Immunology 66, pages 101725.
Crossref
Beáta Biri-Kovács, Zoltán Bánóczi, Anitha Tummalapally & Ildikó Szabó. (2023) Peptide Vaccines in Melanoma: Chemical Approaches towards Improved Immunotherapeutic Efficacy. Pharmaceutics 15:2, pages 452.
Crossref
Angelina Kovalenko, Ekaterina Ryabchevskaya, Ekaterina Evtushenko, Nikolai Nikitin & Olga Karpova. (2023) Recombinant Protein Vaccines against Human Betacoronaviruses: Strategies, Approaches and Progress. International Journal of Molecular Sciences 24:2, pages 1701.
Crossref
Maria Vieito, Simona Casalino, Montse Moreno & Katerina Rojas. 2023. New Insights Into Glioblastoma. New Insights Into Glioblastoma 505 513 .
Yanhong Chu, Lingyu Qian, Yaohua Ke, Xiaoyu Feng, Xinjie Chen, Fangcen Liu, Lixia Yu, Lianru Zhang, Yaping Tao, Rui Xu, Jia Wei, Baorui Liu & Qin Liu. (2022) Lymph node-targeted neoantigen nanovaccines potentiate anti-tumor immune responses of post-surgical melanoma. Journal of Nanobiotechnology 20:1.
Crossref
Melika HaghighiAkbar Khorasani, Pegah KarimiRouhollah KeshavarzMehdi Mahdavi. (2022) Different Formulations of Inactivated SARS-CoV-2 Vaccine Candidates in Human Compatible Adjuvants: Potency Studies in Mice Showed Different Platforms of Immune Responses. Viral Immunology 35:10, pages 663-672.
Crossref
Meruert Babayeva, Kairat Tabynov, Tair Nurpeisov, Gleb Fomin, Gourapura J. Renukaradhya, Nikolai Petrovsky & Kaissar Tabynov. (2022) A recombinant Artemisia vulgaris pollen adjuvanted Art v 1 protein-based vaccine treats allergic rhinitis and bronchial asthma using pre- and co-seasonal ultrashort immunotherapy regimens in sensitized mice. Frontiers in Immunology 13.
Crossref
Danyang Wang, Yongjuan Zou, Ning Wang & Jie Wu. (2022) Chitosan hydrochloride salt stabilized emulsion as vaccine adjuvant. Carbohydrate Polymers 296, pages 119879.
Crossref
Jens Bauer, Natalie Köhler, Yacine Maringer, Philip Bucher, Tatjana Bilich, Melissa Zwick, Severin Dicks, Annika Nelde, Marissa Dubbelaar, Jonas Scheid, Marcel Wacker, Jonas S. Heitmann, Sarah Schroeder, Jonas Rieth, Monika Denk, Marion Richter, Reinhild Klein, Irina Bonzheim, Julia Luibrand, Ursula Holzer, Martin Ebinger, Ines B. Brecht, Michael Bitzer, Melanie Boerries, Judith Feucht, Helmut R. Salih, Hans-Georg Rammensee, Stephan Hailfinger & Juliane S. Walz. (2022) The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma. Nature Communications 13:1.
Crossref
Vivek P. Varma, Mohammad Kadivella, Ajay Kumar, Sridhar Kavela & Syed M. Faisal. (2022) LigA formulated in AS04 or Montanide ISA720VG induced superior immune response compared to alum, which correlated to protective efficacy in a hamster model of leptospirosis. Frontiers in Immunology 13.
Crossref
Fredrik Oftung, Lisbeth M. Næss, Ida Laake, Gregory Stoloff & Olga Pleguezuelos. (2022) FLU-v, a Broad-Spectrum Influenza Vaccine, Induces Cross-Reactive Cellular Immune Responses in Humans Measured by Dual IFN-γ and Granzyme B ELISpot Assay. Vaccines 10:9, pages 1528.
Crossref
Marit M Melssen, Caroline T Fisher, Craig L Slingluff & Cornelis J M Melief. (2022) Peptide emulsions in incomplete Freund’s adjuvant create effective nurseries promoting egress of systemic CD4 + and CD8 + T cells for immunotherapy of cancer . Journal for ImmunoTherapy of Cancer 10:9, pages e004709.
Crossref
Chongming Jiang, Jianrong Li, Wei Zhang, Zhenkun Zhuang, Geng Liu, Wei Hong, Bo Li, Xiuqing Zhang & Cheng-Chi Chao. (2022) Potential association factors for developing effective peptide-based cancer vaccines. Frontiers in Immunology 13.
Crossref
Jingyi Fan, Shengbin Jin, Lachlan Gilmartin, Istvan Toth, Waleed M. Hussein & Rachel J. Stephenson. (2022) Advances in Infectious Disease Vaccine Adjuvants. Vaccines 10:7, pages 1120.
Crossref
Mahnaz Rezaei, Natalia D. Danilova, Mojdeh Soltani, Lyudmila V. Savvateeva, Vadim V. Tarasov, Mazdak Ganjalikhani-Hakemi, Alexandr V. Bazhin & Andrey A. Zamyatnin. (2022) Cancer Vaccine in Cold Tumors: Clinical Landscape, Challenges, and Opportunities. Current Cancer Drug Targets 22:6, pages 437-453.
Crossref
Bogala Mallikharjuna Reddy. 2022. Nanovaccinology as Targeted Therapeutics. Nanovaccinology as Targeted Therapeutics 21 52 .
Lisa Luu, Germanus S. Bah, Ndode Herman Okah-Nnane, Catherine S. Hartley, Alexandra F. Glover, Tessa R. Walsh, Lu-Yun Lian, Bin Zhan, Maria Elena Bottazzi, David Abraham, Nikolai Petrovsky, Nicolas Bayang, Bernard Tangwa, Rene Billingwe Ayiseh, Glory Enjong Mbah, David D. Ekale, Vincent N. Tanya, Sara Lustigman, Benjamin L. Makepeace & John Graham-Brown. (2022) Co-Administration of Adjuvanted Recombinant Ov-103 and Ov-RAL-2 Vaccines Confer Protection against Natural Challenge in A Bovine Onchocerca ochengi Infection Model of Human Onchocerciasis. Vaccines 10:6, pages 861.
Crossref
Joanna Goscianska, Ralph Freund & Stefan Wuttke. (2021) Nanoscience versus Viruses: The SARS‐CoV‐2 Case. Advanced Functional Materials 32:14.
Crossref
Kairat Tabynov, Meruert Babayeva, Tair Nurpeisov, Gleb Fomin, Temirzhan Nurpeisov, Ulbossyn Saltabayeva, Sankar Renu, Gourapura J. Renukaradhya, Nikolai Petrovsky & Kaissar Tabynov. (2022) Evaluation of a Novel Adjuvanted Vaccine for Ultrashort Regimen Therapy of Artemisia Pollen-Induced Allergic Bronchial Asthma in a Mouse Model. Frontiers in Immunology 13.
Crossref
Noraini Abd-Aziz & Chit Laa Poh. (2022) Development of Peptide-Based Vaccines for Cancer. Journal of Oncology 2022, pages 1-17.
Crossref
Albert To, Chih-Yun Lai, Teri Ann S. Wong, Madhuri Namekar, Michael M. Lieberman & Axel T. Lehrer. (2022) Adjuvants Differentially Modulate the Immunogenicity of Lassa Virus Glycoprotein Subunits in Mice. Frontiers in Tropical Diseases 3.
Crossref
Yester F. Janssen, Eline A. Feitsma, Hendrikus H. Boersma, David G. Alleva, Thomas M. Lancaster, Thillainaygam Sathiyaseelan, Sylaja Murikipudi, Andrea R. Delpero, Melanie M. Scully, Ramya Ragupathy, Sravya Kotha, Jeffrey R. Haworth, Nishit J. Shah, Vidhya Rao, Shashikant Nagre, Shannon E. Ronca, Freedom M. Green, Ari Aminetzah, Frans Sollie, Schelto Kruijff, Maarten Brom, Gooitzen M. van Dam & Todd C. Zion. (2022) Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452. Vaccine 40:9, pages 1253-1260.
Crossref
Jonas S. Heitmann, Tatjana Bilich, Claudia Tandler, Annika Nelde, Yacine Maringer, Maddalena Marconato, Julia Reusch, Simon Jäger, Monika Denk, Marion Richter, Leonard Anton, Lisa Marie Weber, Malte Roerden, Jens Bauer, Jonas Rieth, Marcel Wacker, Sebastian Hörber, Andreas Peter, Christoph Meisner, Imma Fischer, Markus W. Löffler, Julia Karbach, Elke Jäger, Reinhild Klein, Hans-Georg Rammensee, Helmut R. Salih & Juliane S. Walz. (2021) A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity. Nature 601:7894, pages 617-622.
Crossref
Fatemeh Namazi, Saba Davoodi & Azam Bolhassani. (2022) Comparison of the Efficacy of HIV-1 Nef-Tat-Gp160-p24 Polyepitope Vaccine Candidate with Nef Protein in Different Immunization Strategies. Current Drug Delivery 19:1, pages 142-156.
Crossref
Juan-Carlos Carrillo, Hua Shen, Fayaz Momin, Olaf Kral, Holger Schnieder & Susanne Kühn. (2022) GTL synthetic paraffin oil shows low liver and tissue retention compared to mineral oil. Food and Chemical Toxicology 159, pages 112701.
Crossref
Soonbum Kwon & Yoon Yeo. 2022. Systemic Drug Delivery Strategies. Systemic Drug Delivery Strategies 483 528 .
Dharmendra Kumar Khatri, Jitender Madan, Kiran Jyoti & Shashi Bala Singh. 2022. Multifunctional Nanocarriers. Multifunctional Nanocarriers 347 377 .
Cheryl L.-L. Chiang & Lana E. Kandalaft. 2022. Cancer Vaccines as Immunotherapy of Cancer. Cancer Vaccines as Immunotherapy of Cancer 21 49 .
Zrinka Matić & Maja Šantak. (2021) Current view on novel vaccine technologies to combat human infectious diseases. Applied Microbiology and Biotechnology 106:1, pages 25-56.
Crossref
Farrhana Ziana Firdaus, Mariusz Skwarczynski & Istvan Toth. 2022. Vaccine Design. Vaccine Design 145 178 .
Hueng-Chuen Fan, Fung-Wei Chang, Jeng-Dau Tsai, Kao-Min Lin, Chuan-Mu Chen, Shinn-Zong Lin, Ching-Ann Liu & Horng-Jyh Harn. (2021) Telomeres and Cancer. Life 11:12, pages 1405.
Crossref
Alina Popa & Sebastian Springer. (2021) Tailored Nanoparticles as Vaccine Components. Applied Sciences 11:24, pages 11898.
Crossref
Zhaojin Yu, Wensi Liu, Ying He, Mingli Sun, Jiankun Yu, Xue Jiao, Qiang Han, Haichao Tang, Bing Zhang, Yunkai Xian, Jing Qi, Jing Gong, Wang Xin, Gang Shi, Fengping Shan, Rui Zhang, Jianping Li & Minjie Wei. (2021) HLA-A2.1-restricted ECM1-derived epitope LA through DC cross-activation priming CD8+ T and NK cells: a novel therapeutic tumour vaccine. Journal of Hematology & Oncology 14:1.
Crossref
Ebrahim Kord, Farzin Roohvand, Jean Dubuisson, Thibaut Vausselin, Hosein Nasr Azadani, Abolfazl Keshavarz, Ahmad Nejati & Katayoun Samimi-Rad. (2021) BacMam virus-based surface display for HCV E2 glycoprotein induces strong cross-neutralizing antibodies and cellular immune responses in vaccinated mice. Infectious Agents and Cancer 16:1.
Crossref
G. Antonarelli, C. Corti, P. Tarantino, L. Ascione, J. Cortes, P. Romero, E.A. Mittendorf, M.L. Disis & G. Curigliano. (2021) Therapeutic cancer vaccines revamping: technology advancements and pitfalls. Annals of Oncology 32:12, pages 1537-1551.
Crossref
Malte Roerden & Juliane S. Walz. (2021) TumorimpfstoffeCancer vaccines. best practice onkologie 16:12, pages 572-580.
Crossref
Orsolya Lőrincz, József Tóth, Levente Molnár, István Miklós, Kata Pántya, Mónika Megyesi, Eszter Somogyi, Zsolt Csiszovszki & Enikő R. Tőke. (2021) In Silico Model Estimates the Clinical Trial Outcome of Cancer Vaccines. Cells 10:11, pages 3048.
Crossref
Malte Roerden & Juliane S. Walz. (2021) TumorimpfstoffeCancer vaccines. Der Onkologe 27:11, pages 1101-1108.
Crossref
David G. Alleva, Andrea R. Delpero, Melanie M. Scully, Sylaja Murikipudi, Ramya Ragupathy, Emma K. Greaves, Thillainaygam Sathiyaseelan, Jeffrey R. Haworth, Nishit J. Shah, Vidhya Rao, Shashikant Nagre, Thomas M. Lancaster, Sarah S. Webb, Allison I. Jasa, Shannon E. Ronca, Freedom M. Green, Hanne Andersen Elyard, JoAnn Yee, Jeffrey Klein, Larry Karnes, Frans Sollie & Todd C. Zion. (2021) Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452. Vaccine 39:45, pages 6601-6613.
Crossref
Srinivasa Reddy Bonam, Laurent Rénia, Ganesh Tadepalli, Jagadeesh Bayry & Halmuthur Mahabalarao Sampath Kumar. (2021) Plasmodium falciparum Malaria Vaccines and Vaccine Adjuvants. Vaccines 9:10, pages 1072.
Crossref
Mohammad Ali Savoji, Mohammad Mehdi Adibzadeh Sereshgi, Seyed Mohammad Mahdi Ghahari, Fatemeh Asgarhalvaei & Mehdi Mahdavi. (2021) Formulation of HBsAg in Montanide ISA 51VG adjuvant: Immunogenicity study and monitoring long-lived humoral immune responses. International Immunopharmacology 96, pages 107599.
Crossref
Stephen C. Frederico, John C. Hancock, Emily E. S. Brettschneider, Nivedita M. Ratnam, Mark R. Gilbert & Masaki Terabe. (2021) Making a Cold Tumor Hot: The Role of Vaccines in the Treatment of Glioblastoma. Frontiers in Oncology 11.
Crossref
Maryam Behzadi, Bahareh Vakili, Alireza Ebrahiminezhad & Navid Nezafat. (2021) Iron nanoparticles as novel vaccine adjuvants. European Journal of Pharmaceutical Sciences 159, pages 105718.
Crossref
Saba Davoodi, Azam Bolhassani & Fatemeh Namazi. (2021) In vivo delivery of a multiepitope peptide and Nef protein using novel cell-penetrating peptides for development of HIV-1 vaccine candidate. Biotechnology Letters 43:3, pages 547-559.
Crossref
Stefania Cuzzubbo, Sara Mangsbo, Divya Nagarajan, Kinana Habra, Alan Graham Pockley & Stephanie E. B. McArdle. (2021) Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments. Frontiers in Immunology 11.
Crossref
Abdellatif Bouazzaoui, Ahmed A. H. Abdellatif, Faisal A. Al-Allaf, Neda M. Bogari, Saied Al-Dehlawi & Sameer H. Qari. (2021) Strategies for Vaccination: Conventional Vaccine Approaches Versus New-Generation Strategies in Combination with Adjuvants. Pharmaceutics 13:2, pages 140.
Crossref
Fabiana Mahylowski Rinaldi, Emanuelle Baldo Gaspar, Luciana Tendolini Brito & Elizabeth De Gaspari. (2021) Immunogenicity of antigens from outer membrane vesicles of Neisseria meningitidis associated with bilayer fragment of dioctadecyldimethylammonium in Swiss adult mice . Clinical and Experimental Vaccine Research 10:2, pages 106.
Crossref
Manju Nagpal, Malkiet Kaur, Manjinder Singh & Geeta Aggarwal. 2021. Strategies to Overcome Superbug Invasions. Strategies to Overcome Superbug Invasions 227 268 .
Annika Nelde, Hans-Georg Rammensee & Juliane S. Walz. (2021) The Peptide Vaccine of the Future. Molecular & Cellular Proteomics 20, pages 100022.
Crossref
Mona Kamal Saadeldin, Amal Kamal Abdel-Aziz & Ahmed Abdellatif. (2021) Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis. Medical Hypotheses 146, pages 110365.
Crossref
Jagannath Mondal, Vishnu Revuri, Mohammad Nazmul Hasan & Yong-kyu Lee. 2021. Bioinspired and Biomimetic Materials for Drug Delivery. Bioinspired and Biomimetic Materials for Drug Delivery 139 170 .
Ashlynn L.Z. Lee, Chuan Yang, Shujun Gao, Yanming Wang, James L. Hedrick & Yi Yan Yang. (2020) Biodegradable Cationic Polycarbonates as Vaccine Adjuvants. ACS Applied Materials & Interfaces 12:47, pages 52285-52297.
Crossref
Sören Reinke, Aneesh Thakur, Cillian Gartlan, Jelena S. Bezbradica & Anita Milicic. (2020) Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants. Vaccines 8:3, pages 554.
Crossref
Tania Gupta & Shishir K Gupta. (2020) Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses. International Immunopharmacology 86, pages 106717.
Crossref
Vishnu Jayaprakash, Maxime Costalonga, Somayajulu Dhulipala & Kripa K. Varanasi. (2020) Enhancing the Injectability of High Concentration Drug Formulations Using Core Annular Flows. Advanced Healthcare Materials 9:18.
Crossref
Yongjuan Zou, Nan Wu, Chunyu Miao, Hua Yue, Jie Wu & Guanghui Ma. (2020) A novel multiple emulsion enhanced immunity via its biomimetic delivery approach . Journal of Materials Chemistry B 8:33, pages 7365-7374.
Crossref
Simone Negrini, Raffaele De Palma & Gilberto Filaci. (2020) Anti-Cancer Immunotherapies Targeting Telomerase. Cancers 12:8, pages 2260.
Crossref
Kirsty L. Wilson, Sue D. Xiang & Magdalena Plebanski. (2020) Functional Recognition by CD8+ T Cells of Epitopes with Amino Acid Variations Outside Known MHC Anchor or T Cell Receptor Recognition Residues. International Journal of Molecular Sciences 21:13, pages 4700.
Crossref
Chunting He, Ming Qin & Xun Sun. (2020) Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight. Acta Pharmaceutica Sinica B 10:7, pages 1175-1191.
Crossref
Lambros Tselikas, Thierry de Baere, Thomas Isoardo, Sandrine Susini, Karine Ser-Le Roux, Mélanie Polrot, Julien Adam, Mathieu Rouanne, Laurence Zitvogel, Laurence Moine, Fréderic Deschamps & Aurélien Marabelle. (2020) Pickering emulsions with ethiodized oil and nanoparticles for slow release of intratumoral anti-CTLA4 immune checkpoint antibodies. Journal for ImmunoTherapy of Cancer 8:1, pages e000579.
Crossref
Yu Zhang, Miao‐Deng Liu, Chu‐Xin Li, Bin Li & Xian‐Zheng Zhang. (2020) Tumor Cell Membrane‐Coated Liquid Metal Nanovaccine for Tumor Prevention ǂ . Chinese Journal of Chemistry 38:6, pages 595-600.
Crossref
Flavia Franco da Cunha, Vinicius Andrade-Oliveira, Danilo Candido de Almeida, Tamiris Borges da Silva, Cristiane Naffah de Souza Breda, Mario Costa Cruz, Eliana L. Faquim-Mauro, Marcos Antonio Cenedeze, Meire Ioshie Hiyane, Alvaro Pacheco-Silva, Regiane Aparecida Cavinato, Ana Claudia Torrecilhas & Niels Olsen Saraiva Câmara. (2020) Extracellular Vesicles isolated from Mesenchymal Stromal Cells Modulate CD4+ T Lymphocytes Toward a Regulatory Profile. Cells 9:4, pages 1059.
Crossref
Nicola Relitti, Akella P. Saraswati, Stefano Federico, Tuhina Khan, Margherita Brindisi, Daniela Zisterer, Simone Brogi, Sandra Gemma, Stefania Butini & Giuseppe Campiani. (2020) Telomerase-based Cancer Therapeutics: A Review on their Clinical Trials. Current Topics in Medicinal Chemistry 20:6, pages 433-457.
Crossref
Olga PleguezuelosJoep DilleSofie de GroenFredrik OftungHubert G.M. NiestersMd Atiqul IslamLisbeth Meyer NæssOlav HungnesNuhoda AldarijDemi L. IdemaAna Fernandez PerezEmma JamesHenderik W. FrijlinkGregory StoloffPaul GroeneveldEelko Hak. (2020) Immunogenicity, Safety, and Efficacy of a Standalone Universal Influenza Vaccine, FLU-v, in Healthy Adults. Annals of Internal Medicine 172:7, pages 453.
Crossref
Wei-Chiao Huang, Bingbing Deng, Amal Seffouh, Joaquin Ortega, Carole A. Long, Ragavan V. Suresh, Xuedan He, Kazutoyo Miura, Shwu-Maan Lee, Yimin Wu & Jonathan F. Lovell. (2020) Antibody response of a particle-inducing, liposome vaccine adjuvant admixed with a Pfs230 fragment. npj Vaccines 5:1.
Crossref
Zhi-Biao Wang & Jing Xu. (2020) Better Adjuvants for Better Vaccines: Progress in Adjuvant Delivery Systems, Modifications, and Adjuvant–Antigen Codelivery. Vaccines 8:1, pages 128.
Crossref
Ali Namvar, Heidar Ali Panahi, Elnaz Agi & Azam Bolhassani. (2020) Development of HPV16,18,31,45 E5 and E7 peptides-based vaccines predicted by immunoinformatics tools. Biotechnology Letters 42:3, pages 403-418.
Crossref
Mehdi kheirollahpour, Mohsen Mehrabi, Naser Mohammadpour Dounighi, Mohsen Mohammadi & Alireza Masoudi. (2020) Nanoparticles and Vaccine Development. Pharmaceutical Nanotechnology 8:1, pages 6-21.
Crossref
Thomas Ebensen, Barbara Fuchs, Kai Schulze & Carlos Alberto Guzmán. 2020. Health Consequences of Microbial Interactions with Hydrocarbons, Oils, and Lipids. Health Consequences of Microbial Interactions with Hydrocarbons, Oils, and Lipids 285 315 .
Sumera Younis, Bart W. Faber, Clemens H.M. Kocken & Edmond J. Remarque. (2019) Identification of adjuvants for clinical trials performed with Plasmodium falciparum AMA1 in rabbits. BMC Immunology 20:1.
Crossref
Neda Kordalivand, Elena Tondini, Chun Yin Jerry Lau, Tina Vermonden, Enrico Mastrobattista, Wim E. Hennink, Ferry Ossendorp & Cornelus F. van Nostrum. (2019) Cationic synthetic long peptides-loaded nanogels: An efficient therapeutic vaccine formulation for induction of T-cell responses. Journal of Controlled Release 315, pages 114-125.
Crossref
Karin L. Lee, Stephen C. Benz, Kristin C. Hicks, Andrew Nguyen, Sofia R. Gameiro, Claudia Palena, John Z. Sanborn, Zhen Su, Peter Ordentlich, Lars Rohlin, John H. Lee, Shahrooz Rabizadeh, Patrick Soon-Shiong, Kayvan Niazi, Jeffrey Schlom & Duane H. Hamilton. (2019) Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial Immunotherapy. Cancer Immunology Research 7:8, pages 1359-1370.
Crossref
Sneha Ratnapriya, Keerti, Amogh A. Sahasrabuddhe & Anuradha Dube. (2019) Visceral leishmaniasis: An overview of vaccine adjuvants and their applications. Vaccine 37:27, pages 3505-3519.
Crossref
Jessica N. McCaffery, Jairo A. Fonseca, Balwan Singh, Monica Cabrera-Mora, Caitlin Bohannon, Joshy Jacob, Myriam Arévalo-Herrera & Alberto Moreno. (2019) A Multi-Stage Plasmodium vivax Malaria Vaccine Candidate Able to Induce Long-Lived Antibody Responses Against Blood Stage Parasites and Robust Transmission-Blocking Activity. Frontiers in Cellular and Infection Microbiology 9.
Crossref
Shuting Shi, Haoru Zhu, Xinyu Xia, Zhihui Liang, Xuehu Ma & Bingbing Sun. (2019) Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity. Vaccine 37:24, pages 3167-3178.
Crossref
Danina Krajišnik, Tanja Ilić, Ines Nikolić & Snežana Savić. (2019) Established and advanced adjuvants in vaccines' formulation: Mineral adsorbents, nanoparticulate carriers and microneedle delivery systems. Arhiv za farmaciju 69:6, pages 420-451.
Crossref
Thomas Ebensen, Barbara Fuchs, Kai Schulze & Carlos Alberto Guzmán. 2018. Health Consequences of Microbial Interactions with Hydrocarbons, Oils, and Lipids. Health Consequences of Microbial Interactions with Hydrocarbons, Oils, and Lipids 1 31 .
Anna-Mari Reid & Namrita Lall. 2019. Medicinal Plants. Medicinal Plants 187 213 .
Heather L. Kinkead, Alexander Hopkins, Eric Lutz, Annie A. Wu, Mark Yarchoan, Kayla Cruz, Skylar Woolman, Teena Vithayathil, Laura H. Glickman, Chudi O. Ndubaku, Sarah M. McWhirter, Thomas W. DubenskyJr.Jr., Todd D. Armstrong, Elizabeth M. Jaffee & Neeha Zaidi. (2018) Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer. JCI Insight 3:20.
Crossref
Hossam H Tayeb & Frank Sainsbury. (2018) Nanoemulsions in drug delivery: formulation to medical application. Nanomedicine 13:19, pages 2507-2525.
Crossref
Ara G. Hovanessian, Calaiselvy Soundaramourty, Rima Benferhat, Roger Le Grand, Nathalie Dereuddre-Bosquet, Bernard Krust & Jérôme Estaquier. (2018) Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques. Journal of Virology 92:18.
Crossref
Kelly D. Moynihan, Rebecca L. Holden, Naveen K. Mehta, Chensu Wang, Mark R. Karver, Jens Dinter, Simon Liang, Wuhbet Abraham, Mariane B. Melo, Angela Q. Zhang, Na Li, Sylvie Le Gall, Bradley L. Pentelute & Darrell J. Irvine. (2018) Enhancement of Peptide Vaccine Immunogenicity by Increasing Lymphatic Drainage and Boosting Serum Stability. Cancer Immunology Research 6:9, pages 1025-1038.
Crossref
Xuedan He, Scott I. Abrams & Jonathan F. Lovell. (2018) Peptide Delivery Systems for Cancer Vaccines. Advanced Therapeutics 1:5, pages 1800060.
Crossref
Zhuting Hu, Patrick A. Ott & Catherine J. Wu. (2017) Towards personalized, tumour-specific, therapeutic vaccines for cancer. Nature Reviews Immunology 18:3, pages 168-182.
Crossref
Eva van Doorn, Olga Pleguezuelos, Heng Liu, Ana Fernandez, Robin Bannister, Gregory Stoloff, Fredrik Oftung, Stephen Norley, Anke Huckriede, Henderik W. Frijlink & Eelko Hak. (2017) Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial. BMC Infectious Diseases 17:1.
Crossref
Hai-Qiu Ma, Forough Ebrahimi, Bin-Seng Low, Nurzalina Abdul Karim Khan & Kit-Lam Chan. (2017) Polar Quassinoids in Standardized Eurycoma longifolia Extract Formulated into a Lipid-Based Solid Dispersion to Improve Rat Sperm Count . Phytotherapy Research 31:12, pages 1875-1882.
Crossref
Velasco Cimica & Jose M. Galarza. (2017) Adjuvant formulations for virus-like particle (VLP) based vaccines. Clinical Immunology 183, pages 99-108.
Crossref
Ruan F.V. Medrano, Aline Hunger, Samir Andrade Mendonça, José Alexandre M. Barbuto & Bryan E. Strauss. (2017) Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy. Oncotarget 8:41, pages 71249-71284.
Crossref
Srinivasa Reddy Bonam, Charalambos D. Partidos, Sampath Kumar M. Halmuthur & Sylviane Muller. (2017) An Overview of Novel Adjuvants Designed for Improving Vaccine Efficacy. Trends in Pharmacological Sciences 38:9, pages 771-793.
Crossref
Philippe O. Gannon, Petra Baumgaertner, Alexandre Huber, Emanuela M. Iancu, Laurène Cagnon, Samia Abed Maillard, Hélène Maby-El Hajjami, Daniel E. Speiser & Nathalie Rufer. (2017) Rapid and Continued T-Cell Differentiation into Long-term Effector and Memory Stem Cells in Vaccinated Melanoma Patients. Clinical Cancer Research 23:13, pages 3285-3296.
Crossref
Christopher J. Genito, Zoltan Beck, Timothy W. Phares, Fanta Kalle, Keith J. Limbach, Maureen E. Stefaniak, Noelle B. Patterson, Elke S. Bergmann-Leitner, Norman C. Waters, Gary R. Matyas, Carl R. Alving & Sheetij Dutta. (2017) Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013. Vaccine 35:31, pages 3865-3874.
Crossref
Susheel K. Singh, Susan Thrane, Christoph M. Janitzek, Morten A. Nielsen, Thor G. Theander, Michael Theisen, Ali Salanti & Adam F. Sander. (2017) Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display. Vaccine 35:30, pages 3726-3732.
Crossref
Sachin G. Thakkar & Zhengrong Cui. 2017. Vaccine Adjuvants. Vaccine Adjuvants 181 199 .
Lanying Du, Wanbo Tai, Yang Yang, Guangyu Zhao, Qing Zhu, Shihui Sun, Chang Liu, Xinrong Tao, Chien-Te K. Tseng, Stanley Perlman, Shibo Jiang, Yusen Zhou & Fang Li. (2016) Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines. Nature Communications 7:1.
Crossref
Nicolas Riteau, Andrea J. Radtke, Kevin Shenderov, Lara Mittereder, Sandra D. Oland, Sara Hieny, Dragana Jankovic & Alan Sher. (2016) Water-in-Oil–Only Adjuvants Selectively Promote T Follicular Helper Cell Polarization through a Type I IFN and IL-6–Dependent Pathway. The Journal of Immunology 197:10, pages 3884-3893.
Crossref
Lei Dong, Alexandra Helmke, Ari Waisman, Hermann Haller, Andreas Pich & Sibylle von Vietinghoff. (2016) Surface-bound bovine serum albumin carrier protein as present in recombinant cytokine preparations amplifies T helper 17 cell polarization. Scientific Reports 6:1.
Crossref
Shawn R. Makinen, Qin Zhu, Heather L. Davis & Risini D. Weeratna. (2016) CpG-mediated augmentation of CD8+ T-cell responses in mice is attenuated by a water-in-oil emulsion (Montanide ISA-51) but enhanced by an oil-in-water emulsion (IDRI SE). International Immunology 28:9, pages 453-461.
Crossref
Narges Khabazzadeh Tehrani, Mehdi Mahdavi, Fatemeh Maleki, Somayeh Zarrati & Fatemeh Tabatabaie. (2014) The role of Montanide ISA 70 as an adjuvant in immune responses against Leishmania major induced by thiol-specific antioxidant-based protein vaccine. Journal of Parasitic Diseases 40:3, pages 760-767.
Crossref
Mahdi Shokri, Farzin Roohvand, Mohammad Hossein Alimohammadian, Mina Ebrahimirad & Soheila Ajdary. (2016) Comparing Montanide ISA 720 and 50-V2 adjuvants formulated with LmSTI1 protein of Leishmania major indicated the potential cytokine patterns for induction of protective immune responses in BALB/c mice. Molecular Immunology 76, pages 108-115.
Crossref
Burcu Temizoz, Etsushi Kuroda & Ken J. Ishii. (2016) Vaccine adjuvants as potential cancer immunotherapeutics. International Immunology 28:7, pages 329-338.
Crossref
Filipa Lebre, Claire H. Hearnden & Ed C. Lavelle. (2016) Modulation of Immune Responses by Particulate Materials. Advanced Materials 28:27, pages 5525-5541.
Crossref
Jeong-Jun Lee, Aeri Shim, Song Yi Lee, Bo-Eun Kwon, Seong Ryeol Kim, Hyun-Jeong Ko & Hyun-Jong Cho. (2016) Ready-to-use colloidal adjuvant systems for intranasal immunization. Journal of Colloid and Interface Science 467, pages 121-128.
Crossref
Kirsty L. Wilson, Sue D. Xiang & Magdalena Plebanski. (2016) A Model to Study the Impact of Polymorphism Driven Liver-Stage Immune Evasion by Malaria Parasites, to Help Design Effective Cross-Reactive Vaccines. Frontiers in Microbiology 7.
Crossref
Burcu Temizoz, Etsushi Kuroda, Kouji Kobiyama, Taiki Aoshi & Ken J. Ishii. 2016. Immunotherapy of Cancer. Immunotherapy of Cancer 247 260 .
Xiaoli Chang & Chang-Qing Xia. (2015) Administration of sulfosuccinimidyl-4-[N-maleimidomethyl] cyclohexane-1-carboxylate conjugated GP10025–33 peptide-coupled spleen cells effectively mounts antigen-specific immune response against mouse melanoma. Biochemical and Biophysical Research Communications 468:1-2, pages 46-52.
Crossref
Chetan E. Chitnis, Paushali Mukherjee, Shantanu Mehta, Syed Shams Yazdani, Shikha Dhawan, Ahmad Rushdi Shakri, Rukmini Bharadwaj, Puneet Kumar Gupta, Dhiraj Hans, Suman Mazumdar, Bijender Singh, Sanjeev Kumar, Gaurav Pandey, Varsha Parulekar, Nathalie Imbault, Preethi Shivyogi, Girish Godbole, Krishna Mohan, Odile Leroy, Kavita Singh & Virander S. Chauhan. (2015) Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175. PLOS ONE 10:4, pages e0117820.
Crossref
Sima Rahimian, Marieke F. Fransen, Jan Willem Kleinovink, Jonatan Riis Christensen, Maryam Amidi, Wim E. Hennink & Ferry Ossendorp. (2015) Polymeric nanoparticles for co-delivery of synthetic long peptide antigen and poly IC as therapeutic cancer vaccine formulation. Journal of Controlled Release 203, pages 16-22.
Crossref
Kirsty L. Wilson, Sue D. Xiang & Magdalena Plebanski. (2015) Montanide, Poly I:C and nanoparticle based vaccines promote differential suppressor and effector cell expansion: a study of induction of CD8 T cells to a minimal Plasmodium berghei epitope. Frontiers in Microbiology 6.
Crossref
Pranati Das, Ajay Amit, Shubhankar Kumar Singh, Rajesh Chaudhary, Manas Ranjan Dikhit, Anupam yadav, Krishna Pandey, Vidya Nand Rabi Das, Shanty Sundram, P. Das & Sanjiva Bimal. (2015) Leishmania donovani phosphoproteins pp41 and pp29 re-establishes host protective immune response in visceral leishmaniasis. Parasitology International 64:1, pages 18-25.
Crossref
D. L. F. Portuondo, L. S. Ferreira, A. C. Urbaczek, A. Batista-Duharte & I. Z. Carlos. (2014) Adjuvants and delivery systems for antifungal vaccines: Current state and future developments. Medical Mycology 53:1, pages 69-89.
Crossref
Yimin Wu, Robert E. Sinden, Thomas S. Churcher, Takafumi Tsuboi & Vidadi Yusibov. 2015. 109 152 .
Ruchi R. Shah, Luis A. Brito, Derek T. O’Hagan & Mansoor M. Amiji. 2015. Subunit Vaccine Delivery. Subunit Vaccine Delivery 59 76 .
Anjali Yadava, Cysha E. Hall, JoAnn S. Sullivan, Douglas Nace, Tyrone Williams, William E. Collins, Christian F. Ockenhouse & John W. Barnwell. (2014) Protective Efficacy of a Plasmodium vivax Circumsporozoite Protein-Based Vaccine in Aotus nancymaae Is Associated with Antibodies to the Repeat Region. PLoS Neglected Tropical Diseases 8:10, pages e3268.
Crossref
A.B. Waghmare, N.C. Salvi, R.L. Deopurkar, P.A. Shenoy & J.M. Sonpetkar. (2014) Evaluation of health status of horses immunized with snake venom and montanide adjuvants, IMS 3012 (nanoparticle), ISA 206 and ISA 35 (emulsion based) during polyvalent snake antivenom production: Hematological and biochemical assessment. Toxicon 82, pages 83-92.
Crossref
Liang Zhao, Arjun Seth, Nani Wibowo, Chun-Xia Zhao, Neena Mitter, Chengzhong Yu & Anton P.J. Middelberg. (2014) Nanoparticle vaccines. Vaccine 32:3, pages 327-337.
Crossref
Olga Pleguezuelos, Gregory A Stoloff & Wilson Caparrós-Wanderley. (2013) Synthetic immunotherapy induces HIV virus specific Th1 cytotoxic response and death of an HIV-1 infected human cell line through classic complement activation. Virology Journal 10:1.
Crossref
Atul Tiwari & Ashutosh TiwariGrace Ledet, Levon Bostanian & Tarun Mandal. 2013. Bioengineered Nanomaterials. Bioengineered Nanomaterials 125 148 .
Daniela Fenoglio, Paolo Traverso, Alessia Parodi, Laura Tomasello, Simone Negrini, Francesca Kalli, Florinda Battaglia, Francesca Ferrera, Stefania Sciallero, Giuseppe Murdaca, Maurizio Setti, Alberto Sobrero, Francesco Boccardo, Giuseppe Cittadini, Francesco Puppo, Domenico Criscuolo, Giorgio Carmignani, Francesco Indiveri & Gilberto Filaci. (2013) A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer. Cancer Immunology, Immunotherapy 62:6, pages 1041-1052.
Crossref
A.L. Silva, R.A. Rosalia, A. Sazak, M.G. Carstens, F. Ossendorp, J. Oostendorp & W. Jiskoot. (2013) Optimization of encapsulation of a synthetic long peptide in PLGA nanoparticles: Low-burst release is crucial for efficient CD8+ T cell activation. European Journal of Pharmaceutics and Biopharmaceutics 83:3, pages 338-345.
Crossref
Akhilesh Kumar Shakya & Kutty Selva Nandakumar. (2013) Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases. Journal of The Royal Society Interface 10:79, pages 20120536.
Crossref
Elena Mata, Aiala Salvador, Manoli Igartua, Rosa María Hernández & José Luis Pedraz. (2013) Malaria Vaccine Adjuvants: Latest Update and Challenges in Preclinical and Clinical Research. BioMed Research International 2013, pages 1-19.
Crossref
M. Mazza, M. Alonso-Sande, M.-C. Jones & M. de la Fuente. 2013. Fundamentals of Pharmaceutical Nanoscience. Fundamentals of Pharmaceutical Nanoscience 117 158 .
Kimberly J. Hassett, Pradyot Nandi & Theodore W. Randolph. 2013. Sterile Product Development. Sterile Product Development 145 164 .
Darren R. Flower. 2013. Immunomic Discovery of Adjuvants and Candidate Subunit Vaccines. Immunomic Discovery of Adjuvants and Candidate Subunit Vaccines 155 180 .
Marion Braun, Rachel Perret, Godehard Scholz & Pedro Romero. 2013. Cancer Immunotherapy. Cancer Immunotherapy 111 146 .
Diederik J. Grootendorst, Jithin Jose, Raluca M. Fratila, Martijn Visscher, Aldrik H. Velders, Bennie Ten Haken, Ton G. Van Leeuwen, Wiendelt Steenbergen, Srirang Manohar & Theo J. M. Ruers. (2013) Evaluation of superparamagnetic iron oxide nanoparticles (Endorem®) as a photoacoustic contrast agent for intra-operative nodal staging. Contrast Media & Molecular Imaging 8:1, pages 83-91.
Crossref
Yize Li, Dorian Counor, Peng Lu, Veasna Duong, Yongxin Yu & Vincent Deubel. (2012) Protective immunity to Japanese encephalitis virus associated with anti-NS1 antibodies in a mouse model. Virology Journal 9:1.
Crossref
Suzanne van Duikeren, Marieke F. Fransen, Anke Redeker, Brigitte Wieles, Gerard Platenburg, Willem-Jan Krebber, Ferry Ossendorp, Cornelis J. M. Melief & Ramon Arens. (2012) Vaccine-Induced Effector-Memory CD8+ T Cell Responses Predict Therapeutic Efficacy against Tumors. The Journal of Immunology 189:7, pages 3397-3403.
Crossref
Franklin Fuentes Aguilar, Jesús Junco Barranco, Eddy Bover Fuentes, Lesvia Calzada Aguilera, Yovisleydis Lopez Sáez, María Dolores Castro Santana, Eulogio Pimentel Vázquez, Roberto Basulto Baker, Osvaldo Reyes Acosta, Hilda Garay Pérez & Gerardo Guillén Nieto. (2012) Very Small Size Proteoliposomes (VSSP) and Montanide combination enhance the humoral immuno response in a GnRH based vaccine directed to prostate cancer. Vaccine 30:46, pages 6595-6599.
Crossref
Rachel P. J. Lai, Michael S. Seaman, Paul Tonks, Frank Wegmann, David J. Seilly, Simon D. W. Frost, Celia C. LaBranche, David C. Montefiori, Antu K. Dey, Indresh K. Srivastava, Quentin Sattentau, Susan W. Barnett & Jonathan L. Heeney. (2012) Mixed Adjuvant Formulations Reveal a New Combination That Elicit Antibody Response Comparable to Freund's Adjuvants. PLoS ONE 7:4, pages e35083.
Crossref
S.B. Colavecchia, A. Jolly, B. Fernández, A.M. Fontanals, E. Fernández & S.L. Mundo. (2012) Effect of lipoarabinomannan from Mycobacterium avium subsp avium in Freund’s incomplete adjuvant on the immune response of cattle. Brazilian Journal of Medical and Biological Research 45:2, pages 139-146.
Crossref
Kazuhiro Kakimi, Midori Isobe, Akiko Uenaka, Hisashi Wada, Eiichi Sato, Yuichiro Doki, Jun Nakajima, Yasuyuki Seto, Tomoki Yamatsuji, Yoshio Naomoto, Kenshiro Shiraishi, Nagio Takigawa, Katsuyuki Kiura, Kazuhide Tsuji, Keiji Iwatsuki, Mikio Oka, Linda Pan, Eric W. Hoffman, Lloyd J. Old & Eiichi Nakayama. (2011) A phase I study of vaccination with NY‐ESO‐1f peptide mixed with Picibanil OK‐432 and Montanide ISA‐51 in patients with cancers expressing the NY‐ESO‐1 antigen. International Journal of Cancer 129:12, pages 2836-2846.
Crossref
Marco Tamborrini, Sabine A Stoffel, Nicole Westerfeld, Mario Amacker, Michael Theisen, Rinaldo Zurbriggen & Gerd Pluschke. (2011) Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations. Malaria Journal 10:1.
Crossref
Rosane NM Guerra, Virgínia MG Silva, Luciana S Aragão-França, Pablo R Oliveira, Rodrigo Feitosa, Flavia RF Nascimento & Lain C Pontes-de-Carvalho. (2011) Babassu aqueous extract (BAE) as an adjuvant for T helper (Th)1-dependent immune responses in mice of a Th2 immune response-prone strain. BMC Immunology 12:1.
Crossref
Seung I. Jang, Hyun S. Lillehoj, Sung Hyen Lee, Kyung Woo Lee, Erik P. Lillehoj, François Bertrand, Laurent Dupuis & Sébastien Deville. (2011) Montanide™ IMS 1313 N VG PR nanoparticle adjuvant enhances antigen-specific immune responses to profilin following mucosal vaccination against Eimeria acervulina. Veterinary Parasitology 182:2-4, pages 163-170.
Crossref
Rino Rappuoli & Ennio De GregorioJean Haensler. 2011. Novel Immunologic Adjuvants. Novel Immunologic Adjuvants 28 40 .
S.M. Sivakumar, Mohammed M. Safhi, M. Kannadasan & N. Sukumaran. (2011) Vaccine adjuvants – Current status and prospects on controlled release adjuvancity. Saudi Pharmaceutical Journal 19:4, pages 197-206.
Crossref
J. L. Casey, A. M. Sanalla, D. Tamvakis, C. Thalmann, E. L. Carroll, K. Parisi, A. M. Coley, D. J. Stewart, J. A. Vaughan, W. P. Michalski, R. Luke & M. Foley. (2011) Peptides specific for Mycobacterium avium subspecies paratuberculosis infection: diagnostic potential. Protein Engineering Design and Selection 24:8, pages 589-596.
Crossref
Alexander Batista-Duharte, Erik B. Lindblad & Ernesto Oviedo-Orta. (2011) Progress in understanding adjuvant immunotoxicity mechanisms. Toxicology Letters 203:2, pages 97-105.
Crossref
Daming Zhu, Holly McClellan, Weili Dai, Elizabeth Gebregeorgis, Mary Anne Kidwell, Joan Aebig, Kelly M. Rausch, Laura B. Martin, Ruth D. Ellis, Louis Miller & Yimin Wu. (2011) Long term stability of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with Montanide® ISA 720 and stabilized with glycine. Vaccine 29:20, pages 3640-3645.
Crossref
Luis J. Cruz, Felix Rueda, Begoña Cordobilla, Lorena Simón, Leticia Hosta, Fernando Albericio & Joan Carles Domingo. (2010) Targeting Nanosystems to Human DCs via Fc Receptor as an Effective Strategy to Deliver Antigen for Immunotherapy. Molecular Pharmaceutics 8:1, pages 104-116.
Crossref
Vanusa P. da Hora, Fabricio R. Conceição, Odir A. Dellagostin & Denise L. Doolan. (2011) Non-toxic derivatives of LT as potent adjuvants. Vaccine 29:8, pages 1538-1544.
Crossref
Michelle J Hickey, Colin C Malone, Kate L Erickson, Martin R Jadus, Robert M Prins, Linda M Liau & Carol A Kruse. (2010) Cellular and vaccine therapeutic approaches for gliomas. Journal of Translational Medicine 8:1.
Crossref
Li-Ching Peng, Chi-Hsien Liu, Chang-Chin Kwan & Keh-Feng Huang. (2010) Optimization of water-in-oil nanoemulsions by mixed surfactants. Colloids and Surfaces A: Physicochemical and Engineering Aspects 370:1-3, pages 136-142.
Crossref
William M. Gwinn, Shaun M. Kirwan, Sheena H. Wang, Kathleen A. Ashcraft, Neil L. Sparks, Catherine R. Doil, Tom G. Tlusty, Leslie S. Casey, Susan K. Hollingshead, David E. Briles, Richard S. Dondero, Anthony J. Hickey, W. Michael Foster & Herman F. Staats. (2010) Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1. Vaccine 28:42, pages 6901-6914.
Crossref
Ming-Hsi Huang, Su-Chen Lin, Chia-Hsin Hsiao, Hsin-Ju Chao, Hung-Ren Yang, Chien-Chun Liao, Po-Wei Chuang, Huang-Pi Wu, Chiung-Yi Huang, Chih-Hsiang Leng, Shih-Jen Liu, Hsin-Wei Chen, Ai-Hsiang Chou, Alan Yung-Chih Hu & Pele Chong. (2010) Emulsified Nanoparticles Containing Inactivated Influenza Virus and CpG Oligodeoxynucleotides Critically Influences the Host Immune Responses in Mice. PLoS ONE 5:8, pages e12279.
Crossref
Barney S. Graham, M. Juliana McElrath, Michael C. Keefer, Kyle Rybczyk, David Berger, Kent J. Weinhold, Janet Ottinger, Guido Ferarri, David C. Montefiori, Don Stablein, Carol Smith, Richard Ginsberg, John Eldridge, Ann Duerr, Pat Fast & Barton F. Haynes. (2010) Immunization with Cocktail of HIV-Derived Peptides in Montanide ISA-51 Is Immunogenic, but Causes Sterile Abscesses and Unacceptable Reactogenicity. PLoS ONE 5:8, pages e11995.
Crossref
Geert Leroux-Roels. (2010) Unmet needs in modern vaccinology. Vaccine 28, pages C25-C36.
Crossref
Mark A. Pierce, Ruth D. Ellis, Laura B. Martin, Elissa Malkin, Eveline Tierney, Kazutoyo Miura, Michael P. Fay, Joanne Marjason, Suzanne L. Elliott, Gregory E.D. Mullen, Kelly Rausch, Daming Zhu, Carole A. Long & Louis H. Miller. (2010) Phase 1 safety and immunogenicity trial of the Plasmodium falciparum blood-stage malaria vaccine AMA1-C1/ISA 720 in Australian adults. Vaccine 28:10, pages 2236-2242.
Crossref
T. Ebensen, B. Fuchs, K. Schulze & C. A. Guzmán. 2010. Handbook of Hydrocarbon and Lipid Microbiology. Handbook of Hydrocarbon and Lipid Microbiology 3311 3331 .
Syuan‐Yi Siao, Li‐Hsiu Lin, Wei‐Wen Chen, Ming‐Hsi Huang & Pele Chong. (2009) Characterization and emulsifying properties of block copolymers prepared from lactic acid and poly(ethylene glycol). Journal of Applied Polymer Science 114:1, pages 509-516.
Crossref
Ming-Hsi Huang, Chiung-Yi Huang, Shu-Pei Lien, Syuan-Yi Siao, Ai-Hsiang Chou, Hsin-Wei Chen, Shih-Jen Liu, Chih-Hsiang Leng & Pele Chong. (2009) Development of Multi-Phase Emulsions Based on Bioresorbable Polymers and Oily Adjuvant. Pharmaceutical Research 26:8, pages 1856-1862.
Crossref
Bruno Guy. 2009. Carbohydrate‐Based Vaccines and Immunotherapies. Carbohydrate‐Based Vaccines and Immunotherapies 89 115 .
Anita Schmitt, Clemens Bechter, Junxia Yao, Marlies Goetz, Birgit Maccari, Peter Schauwecker, Markus Wiesneth & Michael Schmitt. (2009) Cytomegalovirus vaccination of leukemia and lymphoma patients after allogeneic stem cell transplantation — Validation of a peptide vaccine. Journal of Immunological Methods 343:2, pages 140-147.
Crossref
Arun Waghmare, R.L. Deopurkar, Nitin Salvi, Milind Khadilkar, Milind Kalolikar & S.K. Gade. (2009) Comparison of Montanide adjuvants, IMS 3012 (Nanoparticle), ISA 206 and ISA 35 (Emulsion based) alongwith incomplete Freund's adjuvant for hyperimmunization of equines used for production of polyvalent snake antivenom. Vaccine 27:7, pages 1067-1072.
Crossref
Rima Benferhat, Frédéric Martinon, Bernard Krust, Roger Le Grand & Ara G. Hovanessian. (2009) The CBD1 peptide corresponding to the caveolin-1 binding domain of HIV-1 glycoprotein gp41 elicits neutralizing antibodies in cynomolgus macaques when administered with the tetanus T helper epitope. Molecular Immunology 46:4, pages 705-712.
Crossref
Thomas Ebensen & Carlos A. Guzmán. 2009. Pharmaceutical Biotechnology. Pharmaceutical Biotechnology 171 188 .
Julia Karbach, Sacha Gnjatic, Armin Bender, Antje Neumann, Eckhart Weidmann, Jianda Yuan, Cathy A. Ferrara, Eric Hoffmann, Lloyd J. Old, Nasser K. Altorki & Elke Jäger. (2009) Tumor-reactive CD8 + T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide® ISA-51: Association with survival . International Journal of Cancer, pages NA-NA.
Crossref
Meta Roestenberg, Ed Remarque, Erik de Jonge, Rob Hermsen, Hildur Blythman, Odile Leroy, Egeruan Imoukhuede, Soren Jepsen, Opokua Ofori-Anyinam, Bart Faber, Clemens H. M. Kocken, Miranda Arnold, Vanessa Walraven, Karina Teelen, Will Roeffen, Quirijn de Mast, W. Ripley Ballou, Joe Cohen, Marie Claude Dubois, St?phane Ascarateil, Andre van der Ven, Alan Thomas & Robert Sauerwein. (2008) Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel?, Montanide ISA 720 or AS02. PLoS ONE 3:12, pages e3960.
Crossref
Bart W. Faber, Edmond J. Remarque, Clemens H.M. Kocken, Pascale Cheront, Doriano Cingolani, Florence Xhonneux, Margarita Jurado, Michele Haumont, Soren Jepsen, Odile Leroy & Alan W. Thomas. (2008) Production, quality control, stability and pharmacotoxicity of cGMP-produced Plasmodium falciparum AMA1 FVO strain ectodomain expressed in Pichia pastoris. Vaccine 26:48, pages 6143-6150.
Crossref
Kristina Abel, Lisa Strelow, Yujuan Yue, Meghan K. Eberhardt, Kimberli A. Schmidt & Peter A. Barry. (2008) A heterologous DNA prime/protein boost immunization strategy for rhesus cytomegalovirus. Vaccine 26:47, pages 6013-6025.
Crossref
Qi Qiu, Richard Yuan-Hu Wang, Xuanmao Jiao, Bo Jin, Fuminaka Sugauchi, Teresa Grandinetti, Harvey J. Alter & J. Wai-Kuo Shih. (2008) Induction of multispecific Th-1 type immune response against HCV in mice by protein immunization using CpG and Montanide ISA 720 as adjuvants. Vaccine 26:43, pages 5527-5534.
Crossref
Yimin Wu, Ruth D. Ellis, Donna Shaffer, Erica Fontes, Elissa M. Malkin, Siddhartha Mahanty, Michael P. Fay, David Narum, Kelly Rausch, Aaron P. Miles, Joan Aebig, Andrew Orcutt, Olga Muratova, Guanhong Song, Lynn Lambert, Daming Zhu, Kazutoyo Miura, Carole Long, Allan Saul, Louis H. Miller & Anna P. Durbin. (2008) Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51. PLoS ONE 3:7, pages e2636.
Crossref
Edmond J. Remarque, Bart W. Faber, Clemens H. M. Kocken & Alan W. Thomas. (2008) A Diversity-Covering Approach to Immunization with Plasmodium falciparum Apical Membrane Antigen 1 Induces Broader Allelic Recognition and Growth Inhibition Responses in Rabbits . Infection and Immunity 76:6, pages 2660-2670.
Crossref
Laura J. Peek, C. Russell Middaugh & Cory Berkland. (2008) Nanotechnology in vaccine delivery. Advanced Drug Delivery Reviews 60:8, pages 915-928.
Crossref

Displaying 200 of 233 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.